摘要
目的：探讨妇科恶性肿瘤患者化疗前后血脂水平的变化及其影响因素。方法：测定312例妇科恶性肿瘤患者化疗前后胆固醇（CHO）、甘油三酯（TG）、低密度脂蛋白（LDL-C）、高密度脂蛋白（HDL-C）水平并记录临床资料进行比较分析。结果：患者经各周期化疗后CHO、LDL-C、HDL-C值均较化疗前明显升高，差异均有统计学意义（P〈0.05）。TG值在第3、4、5个化疗周期后较化疗前明显升高，差异均有统计学意义（P〈0.05）。BMI在各化疗周期后与化疗前比较均差异无统计学意义（P〉0.05）。年龄≥60岁、化疗周期较多（5~8次）患者化疗后血脂升高程度较高（P〈0.05）；肿瘤分期及化疗方案对血脂、BMI变化的影响差异均无统计学意义（P〉0.05）。结论：化疗可使妇科恶性肿瘤患者血脂升高，并在化疗4-5个疗程后达到峰值并维持相对稳定。其中年龄≥60岁、化疗次数较多是引起血脂紊乱的不利因素。
Objective：To investigate the changes and affected factors of blood lipid before and after chemotherapy treatment in patients with gynecologic malignant tumor.Method：312 gynecologic malignant tumor patients were collected. Blood Cholesterol（CHO）,triglycerides（TG）,low density lipoprotein（LDL-C）,high density lipoprotein（HDL-C） and clinical data of patients before and after chemotherapy were analyzed. Result：After each cycle of chemotherapy in patients blood CHO,LDL-C,and HDL-C were higher than before treatment（P〈0.05）. TG was higher after 3-5 cycles of chemotherapy significantly（P〈0.05）. There were no significant difference of body mass index（BMI）（P〉0.05）. Blood lipid of patients（above 60 years old or with range 5-8 cycles of chemotherapy）increased significantly（P〈0.05）. Tumor stage and chemotherapy regiment had no obvious impacts on blood lipid and BMI before and after chemotherapy（P〉0.05）. Conclusion：After chemotherapy blood lipid in patients with gynecological malignant tumor is significantly elevated,it can reach the peak after 4-5 cycles and maintain a relatively stable. Adverse factors of dyslipidemia are age≥60 and multiple chemotherapy.
出处
《中国医学创新》
CAS
2014年第7期9-12,共4页
Medical Innovation of China
关键词
妇科恶性肿瘤
化疗
血脂
体重指数
Gynecologic malignant tumor
Chemotherapy
Blood lipid
Body mass index
